Stocks in Focus : Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Recro Pharma, Inc. (NASDAQ:REPH), Excel Trust (NYSE:EXL)

Technology Stocks News 13

Facebook Inc. (NASDAQ:FB), which closed its acquisition of mobile messaging service WhatsApp on Monday, has no near-term plan to make money from the service, Chief Executive Mark Zuckerberg said on Thursday. Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 23.70% and weekly performance is -5.85%. On last trading day company shares ended up $72.91. Facebook Inc (NASDAQ:FB) distance from 50-day simple moving average (SMA50) is -3.74%.

Micron Technology, Inc. (NASDAQ:MU)’s VP Brian Shirley unloaded 30,000 shares of the stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $34.06, for a total transaction of $1,021,800.00. Micron Technology, Inc. (NASDAQ:MU) shares fell -9.30% in last trading session and ended the day at $27.79. MU Gross Margin is 31.80% and its return on assets is 18.00%. Micron Technology, Inc. (NASDAQ:MU) quarterly performance is -17.27%.

Israel’s Can-Fite BioPharma Ltd. (NYSEMKT:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, has received a patent in the US for its drug candidate, CF102, in the treatment of liver regeneration and function following liver surgery. On 10 October, Can-Fite BioPharma Ltd. (NYSEMKT:CANF) shares advanced 3.45% and was closed at $3.12. CANF EPS growth in last 5 year was 0.00%. Can-Fite BioPharma Ltd. (NYSEMKT:CANF) year to date (YTD) performance is -48.01%.

Recro Pharma, Inc. (NASDAQ:REPH) is conducting phase II development of an intranasal formulation for the treatment of cancer pain and post-operative pain. In clinical trials, dexmedetomidine was well tolerated. Recro Pharma, Inc. (NASDAQ:REPH) ended the last trading day at $2.80. Company weekly volatility is calculated as 6.10% and price to cash ratio as 0.78. Recro Pharma, Inc. (NASDAQ:REPH) showed a weekly performance of -14.37%.

Excel Trust, Inc. (NYSE:EXL) a retail focused real estate investment trust (REIT), announced today that its third quarter earnings will be released after the market closes on Wednesday, October 29, 2014. Senior Management will host a conference call the following day, Thursday, October 30, 2014 at 1:00 p.m. Eastern Time. Excel Trust, Inc. (NYSE:EXL) shares advanced 0.08% in last trading session and ended the day at $12.09. EXL Gross Margin is 89.10% and its return on assets is 0.70%. Excel Trust, Inc. (NYSE:EXL) quarterly performance is -6.57%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone